摘要
目的:探讨血清降钙素原在肝硬化自发性腹膜炎早期诊断中的临床价值。方法:观察组选择肝硬化自发性腹膜炎患者80例进行血清降钙素原检查,对照组通过腹水常规与腹水培养,比较两组患者治疗前后血清降钙素原水平,临床诊断时间、诊断率,统计治疗1月内预后情况。结果:治疗后观察组血清降钙素原水平显著低于治疗前及对照组(P<0.05),观察组诊断时间显著快于对照组(P<0.05),诊断率高于对照组(P<0.05),临床好转率高于对照组(P<0.05),发生肝性脑病、脓毒血症及临床死亡的比例显著低于对照组(P<0.05)。结论:血清降钙素原测定能有效提高肝硬化自发性腹膜炎诊断率,做到早诊断早治疗,改善患者预后。
Objective ：To investigate the clinical value of serum procalcitonin with the early diagnosis of spontaneous bacterial peritonitis in hepatic cirrhosis .Methods ：80 cases were choosed ,the control group were used ascites training and ascites culture ,the observation group were checked by serum procalcitonin ,then serum procalci‐tonin levels ,clinical diagnosis time ,the diagnosis rate ,statistical treatment in one month were compared before and after treatment .Results ：The observation group after treatment with serum procalcitonin levels were significantly lower than control group（P〈 0 .05） ,the diagnosis time of the observation group was significantly faster than con‐trol group（P〈 0 .05） ,the diagnosis rate was higher than control group（P 〈 0 .05） ,the clinical improvement rate was higher than control group（P〈 0 .05） ,hepatic encephalopathy ,sepsis clinical death ratio were lower than control group（P〈 0 .05） .Conclusion ：Serum procalcitonin measurement can improve the diagnosis of cirrhosis and spontaneous bacterial peritonitis rate ,and early diagnosis and treatment ,so it can improve patient outcomes .
出处
《陕西医学杂志》
CAS
2015年第5期570-572,共3页
Shaanxi Medical Journal
关键词
肝硬化/并发症
腹膜炎/病因学
腹膜炎/诊断
降钙素/代谢
Liver cirrhosis/complication Peritonitis/etiology Peritonitis/diagnosis Procalcitonin/metabolism
